INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,750,350 | -39.1% | 861,400 | -49.1% | 0.16% | -10.6% |
| Q2 2023 | $35,687,464 | +23.8% | 1,691,349 | 0.0% | 0.18% | -3.7% |
| Q1 2023 | $28,837,500 | -6.4% | 1,691,349 | +9.7% | 0.19% | -23.7% |
| Q4 2022 | $30,796,153 | +2.8% | 1,541,349 | +10.8% | 0.24% | +28.3% |
| Q3 2022 | $29,970,000 | +140.5% | 1,391,349 | +120.2% | 0.19% | +161.6% |
| Q2 2022 | $12,460,000 | -16.1% | 631,849 | 0.0% | 0.07% | +9.0% |
| Q1 2022 | $14,848,000 | -69.7% | 631,849 | -64.9% | 0.07% | -63.6% |
| Q4 2021 | $48,983,000 | -1.1% | 1,798,209 | 0.0% | 0.18% | -8.9% |
| Q3 2021 | $49,523,000 | +85.8% | 1,798,209 | +92.0% | 0.20% | +74.1% |
| Q2 2021 | $26,651,000 | -16.4% | 936,438 | 0.0% | 0.12% | -41.1% |
| Q1 2021 | $31,895,000 | +36.6% | 936,438 | +33.5% | 0.20% | +39.7% |
| Q4 2020 | $23,346,000 | – | 701,301 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |